Protein-Protein Interactions in RSV Assembly: Potential Targets for Attenuating RSV Strains

Reena Ghildyal, David Jans, Philip Bardin, John Mills

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) is the major respiratory pathogen of infants and children worldwide, with no effective treatment or vaccine available. Steady progress has been made in understanding the respiratory syncytial virus lifecycle and the consequences of infection, but some areas of RSV still remain poorly understood. Although many of the interactions between virus proteins that are required for efficient RSV assembly have been elucidated, many questions still remain regarding viral assembly, as well as the mechanisms of RSV budding. This review will summarise the current understanding of RSV assembly, including the various interactions between virus proteins and the involvement of cellular factors with a view to identifying possible attenuation and/or drug targets within the assembly pathway.
Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalInfectious Disorders - Drug Targets
Volume12
Issue number2
DOIs
Publication statusPublished - 2012

Fingerprint

Virus Assembly
Respiratory Syncytial Viruses
Proteins
Viruses
Virus Release
Vaccines
Infection
Pharmaceutical Preparations

Cite this

@article{c0dcfcfc1d5b4eae95af40df6c70b2b7,
title = "Protein-Protein Interactions in RSV Assembly: Potential Targets for Attenuating RSV Strains",
abstract = "Respiratory syncytial virus (RSV) is the major respiratory pathogen of infants and children worldwide, with no effective treatment or vaccine available. Steady progress has been made in understanding the respiratory syncytial virus lifecycle and the consequences of infection, but some areas of RSV still remain poorly understood. Although many of the interactions between virus proteins that are required for efficient RSV assembly have been elucidated, many questions still remain regarding viral assembly, as well as the mechanisms of RSV budding. This review will summarise the current understanding of RSV assembly, including the various interactions between virus proteins and the involvement of cellular factors with a view to identifying possible attenuation and/or drug targets within the assembly pathway.",
author = "Reena Ghildyal and David Jans and Philip Bardin and John Mills",
year = "2012",
doi = "10.2174/187152612800100125",
language = "English",
volume = "12",
pages = "103--109",
journal = "Infectious Disorders - Drug Targets",
issn = "1871-5265",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

Protein-Protein Interactions in RSV Assembly: Potential Targets for Attenuating RSV Strains. / Ghildyal, Reena; Jans, David; Bardin, Philip; Mills, John.

In: Infectious Disorders - Drug Targets, Vol. 12, No. 2, 2012, p. 103-109.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protein-Protein Interactions in RSV Assembly: Potential Targets for Attenuating RSV Strains

AU - Ghildyal, Reena

AU - Jans, David

AU - Bardin, Philip

AU - Mills, John

PY - 2012

Y1 - 2012

N2 - Respiratory syncytial virus (RSV) is the major respiratory pathogen of infants and children worldwide, with no effective treatment or vaccine available. Steady progress has been made in understanding the respiratory syncytial virus lifecycle and the consequences of infection, but some areas of RSV still remain poorly understood. Although many of the interactions between virus proteins that are required for efficient RSV assembly have been elucidated, many questions still remain regarding viral assembly, as well as the mechanisms of RSV budding. This review will summarise the current understanding of RSV assembly, including the various interactions between virus proteins and the involvement of cellular factors with a view to identifying possible attenuation and/or drug targets within the assembly pathway.

AB - Respiratory syncytial virus (RSV) is the major respiratory pathogen of infants and children worldwide, with no effective treatment or vaccine available. Steady progress has been made in understanding the respiratory syncytial virus lifecycle and the consequences of infection, but some areas of RSV still remain poorly understood. Although many of the interactions between virus proteins that are required for efficient RSV assembly have been elucidated, many questions still remain regarding viral assembly, as well as the mechanisms of RSV budding. This review will summarise the current understanding of RSV assembly, including the various interactions between virus proteins and the involvement of cellular factors with a view to identifying possible attenuation and/or drug targets within the assembly pathway.

U2 - 10.2174/187152612800100125

DO - 10.2174/187152612800100125

M3 - Article

VL - 12

SP - 103

EP - 109

JO - Infectious Disorders - Drug Targets

JF - Infectious Disorders - Drug Targets

SN - 1871-5265

IS - 2

ER -